Loading organizations...
EchoPixel develops a software platform that transforms standard medical images into interactive, four-dimensional holographic visualizations. This turnkey solution allows physicians to engage with a digital twin of a patient's anatomy, providing real-time situational awareness for complex procedures. The technology enables patient-specific organs and tissues to be experienced as virtual physical objects, enhancing understanding of three-dimensional anatomic relationships without requiring specialized headgear or glasses.
Founded in 2012 by CEO Sergio Aguirre, EchoPixel emerged from the recognition that traditional two-dimensional and two-and-a-half-dimensional medical imaging often presents significant challenges in accurately comprehending complex anatomical structures. This insight drove the creation of a system designed to overcome these limitations, addressing potential procedural complications and inefficiencies stemming from inadequate spatial understanding.
The platform is primarily utilized by physicians, particularly within structural heart and congenital heart programs, where precise anatomical visualization is critical. EchoPixel's overarching vision is to advance precision health by transforming patient care delivery, ultimately enabling more accurate and effective interventions through immersive, interactive medical imaging.
EchoPixel has raised $14.8M across 2 funding rounds.
EchoPixel has raised $14.8M in total across 2 funding rounds.
EchoPixel is a Silicon Valley-based technology company that develops advanced medical imaging solutions, primarily through its flagship product, True3D. This software transforms standard medical images (CT, MRI, ultrasound) into interactive 3D holograms, allowing physicians to visualize and manipulate patient-specific anatomy in an open 3D space. EchoPixel serves healthcare providers, including surgeons and radiologists, by enhancing diagnostic accuracy, surgical planning, and intraoperative guidance, ultimately improving patient outcomes and clinical education[1][2][3].
Founded in 2012 by CEO Sergio Aguirre, EchoPixel emerged from Silicon Valley’s entrepreneurial ecosystem and graduated from Fogarty Innovation in 2018. The idea originated from the need to overcome the limitations of traditional 2D medical imaging by leveraging virtual reality and holography to provide a more intuitive and precise understanding of complex anatomical structures. Early clinical validation showed significant improvements, such as detecting up to 90% more congenital heart defects in newborns and drastically reducing device sizing times, which helped build momentum and attract venture capital[5][3][2].
EchoPixel rides the growing trend of applying augmented reality (AR) and virtual reality (VR) technologies to healthcare, particularly medical imaging and surgical planning. The timing is critical as healthcare increasingly demands precision, minimally invasive procedures, and personalized treatment plans. Market forces such as rising healthcare costs, the need for improved surgical outcomes, and advances in imaging hardware favor EchoPixel’s solutions. By enabling clinicians to interact with patient anatomy in 3D, EchoPixel influences the broader ecosystem by setting new standards for visualization, training, and intraoperative support, potentially paving the way for robotic-assisted surgeries controlled remotely[2][1][3].
Looking ahead, EchoPixel is positioned to expand its clinical adoption globally, seeking regulatory approvals beyond the U.S. and deepening partnerships with healthcare providers and technology firms. Trends such as AI integration, enhanced real-time imaging, and robotic surgery will likely shape its evolution. EchoPixel’s influence may grow as it helps transition medical imaging from flat screens to immersive, interactive environments, fundamentally changing how clinicians diagnose and treat patients. This trajectory aligns with its founding vision of transforming healthcare through cutting-edge visualization technologies[2][5][6].
EchoPixel has raised $14.8M in total across 2 funding rounds.
EchoPixel's investors include Wendell Brooks, Aurus Capital, Binomial, Harris & Harris Group, Lam Research, Runa Capital.
EchoPixel has raised $14.8M across 2 funding rounds. Most recently, it raised $9.0M Series A in October 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2017 | $9.0M Series A | Wendell Brooks | Aurus Capital, Binomial, Harris & Harris Group, Lam Research, Runa Capital |
| May 4, 2016 | $5.8M Seed |